Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

REPORT: State of Oligo, Peptide, mRNA and CRISPR Therapeutics 2019

Download exclusive research

In June 2019 Informa Connect Life Sciences conducted a survey of oligonucleotide, peptide, CRISPR and mRNA therapeutics professionals from around the world. Based on 124 responses, this report gives an overview of how insiders really view the state of the industry, revealing unique insights into potential opportunities and challenges around drug development, manufacture, delivery, technologies, regulations and collaborations. Dan Stanton, editor of BioProcess Insider, introduces the report, exploring what some of the key takeaways mean for the industry.

To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content. Have any questions or interested in sponsoring future content? Email andrew.burrows@informa.com.

Oligo, Peptide, mRNA and CRISPR Therapeutics Report

Create your Informa Connect account

Access this and more industry news, views, and keynotes from influencers and market movers.
You may be interested in attending our "TIDES Europe: Oligonucleotide and Peptide Therapeutics" event.
Please select if you'd like more information on:
Show
Please tick these boxes if you do not wish to receive marketing information relevant to you from Informa Connect:
By creating an account you agree to Informa's Terms of Use and Privacy Policy